arrow
T

Tsutomu Ueda

Hiroshima University Hospital
H指数:21
被引数:4,730

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Live Imaging of Nitric Oxide Dynamics Reveals Cell Type-Specific NO Signaling in Air–Liquid Interface Cultures of Human Sinonasal Epithelial Cells

实时成像揭示一氧化氮动力学在人体鼻窦上皮细胞气-液界面培养中呈现细胞类型特异性NO信号传导

2026-06-150
OA
Rebuilding the Mucociliary Apparatus in ECRS: TSLP/IL-33 Signaling Synergy and the Residual Molecular Scar of DNASE1L3 Following IL-4/13 Blockade

嗜酸性慢性鼻窦炎中纤毛上皮细胞装置的重建:TSLP/IL-33信号协同作用及DNASE1L3残留分子疤痕在IL-4/13阻断后的影响

Cells
IF5.2
2026-05-150
OA
Impact of hearing impairment in unilateral hearing loss: A multicenter study of standardized sound localization tests in Japan (vol 52,pg 690, 2025)

单侧听力损失中听力障碍的影响:日本多中心标准化声源定位测试研究(卷52,页690,2025)

2025-11-010
PRE
Neoadjuvant and Adjuvant Pembrolizumab (Pembro) Plus Standard of Care (SOC) in Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC): Postoperative Risk Subgroup Analysis of KEYNOTE-689

新辅助和辅助帕博利珠单抗(Pembro)联合标准治疗(SOC)在可切除局部晚期头颈鳞状细胞癌(LA HNSCC)中的应用:KEYNOTE-689研究术后风险亚组分析

2025-10-140
PRE
Impact of hearing impairment in unilateral hearing loss: A multicenter study of standardized sound localization tests in Japan

单侧听力损失中听力障碍的影响:日本多中心标准化声音定位测试研究

2025-10-011
OAAI
Association between geriatric 8 (G8) scores and self-care decline in elderly patients with head and neck squamous cell carcinoma undergoing radiotherapy

老年8项评分(G8)与接受放射治疗的头颈部鳞状细胞癌老年患者自我护理能力下降之间的关系

2025-09-160
OA
Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiation therapy for locally advanced maxillary sinus cancer (JCOG1212): final analysis

顺铂超选择性动脉灌注联合同期放射治疗局部晚期上颌窦癌的剂量探索与疗效确证试验(JCOG1212):最终分析

2025-02-060
OA
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)

通过综合分析头颈癌患者的预处理血浆外泌体mrna,鉴定生物标志物以预测nivolumab的治疗反应的全国多中心前瞻性研究 (BIONEXT研究)

2025-01-100
OAAI
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008
2024-10-011
PRE
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma

头颈部鳞状细胞癌中nivolumab反应的临床,基因组和免疫微环境决定因素

2024-07-291
OAAI
Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients with T4aN0M0
2024-04-016
PRE